CN1244594C - Preparation process for ginsenoside Rg1 - Google Patents

Preparation process for ginsenoside Rg1 Download PDF

Info

Publication number
CN1244594C
CN1244594C CN 03148804 CN03148804A CN1244594C CN 1244594 C CN1244594 C CN 1244594C CN 03148804 CN03148804 CN 03148804 CN 03148804 A CN03148804 A CN 03148804A CN 1244594 C CN1244594 C CN 1244594C
Authority
CN
China
Prior art keywords
silica gel
panaxoside
saponin
ethanol
enthanol
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Lifetime
Application number
CN 03148804
Other languages
Chinese (zh)
Other versions
CN1566138A (en
Inventor
唐修文
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Daphne Pharmaceutical Group Co ltd Yunnan
Original Assignee
Individual
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Individual filed Critical Individual
Priority to CN 03148804 priority Critical patent/CN1244594C/en
Publication of CN1566138A publication Critical patent/CN1566138A/en
Application granted granted Critical
Publication of CN1244594C publication Critical patent/CN1244594C/en
Anticipated expiration legal-status Critical
Expired - Lifetime legal-status Critical Current

Links

Landscapes

  • Steroid Compounds (AREA)
  • Medicines Containing Plant Substances (AREA)

Abstract

The present invention relates to a process for preparing a panaxoside monomer, which comprises the following steps: (1) panax notoginseng saponin is taken to be dissolved in 10 to 40% of enthanol to obtain diluted enthanol solution; (2) a pretreated D-101 macroporous resin column is eluted by 20 to 40% enthanol; (3) the enthanol is decompressed and recovered, the solution is sprayed and dried, and panoxatriol saponin is obtained; (4) a small quantity of 60 to 100% ethanol or methanol is added, the panoxatriol saponin is heated and dissolved, the dissolved panoxatriol saponin is adsorbed on 0.3 time to 3 times of silica gel with 40 meshes to 160 meshes to be dried; (5) 10 times to 50 times of silicon gel or thin-layer chromatography silica gel with various particle sizes of 150 meshes to 10 mu to 40 mu is taken to be filled in a column, and the silica gel with adsorbents is filled in the upper part of the silica gel column to carry out dry column chromatography under low pressure; (6) the silica gel is eluted by a chloroform-methanol-water lower-layer solvent system, the eluant is sectionally collected, the solvent is recovered, and a crude product of panaxoside Rg1 is obtained; (7) the crude product of the Rg1 is repeatedly processed according to the steps 4, 5 and 6 to obtain a fine product of the panaxoside Rg 1.

Description

Panaxoside Rg 1Preparation technology
Technical field
The present invention relates to a kind of preparation technology of panaxoside monomer.
Background technology
Chinese patent application CN1293198A (application number 00123074.3) discloses a kind of " preparation method of scarce ginsenoside ", system is dissolved in alkali metal hydroxide in the high boiling point aliphatic alcohols compound, its concentration is generally 0.5%-50%, preferred concentration is 3-15, stirring down, the continuation heat temperature raising carries out basic hydrolysis, hydrolysis temperature is 180 ℃-270 ℃, preferred temperature is the 190-220 ℃ of reaction postcooling thin up to the room temperature that finishes, by organic solvent extraction or large aperture adsorption resin adsorb product of the present invention.And panaxoside Rg 1Preparation technology also do not appear in the newspapers as yet.
Summary of the invention
Purpose of the present invention aims to provide a kind of panaxoside Rg 1Preparation technology.
Panaxoside Rg of the present invention 1Preparation technology is made up of following steps:
(1) get Radix Notoginseng total arasaponins, the dissolve with ethanol with 10-40% obtains dilute alcohol solution;
(2) by through pretreated D-101 macroporous resin column, use the 20-40% ethanol elution;
(3) decompression recycling ethanol, spraying drying gets the Panaxatriol saponin;
(4) add a small amount of 60-100% ethanol or methyl alcohol, heating for dissolving is adsorbed on the 0.3-3 times of 40-160 order silica gel drying;
(5) get 10-50 150 orders doubly and adorn post, the above-mentioned silica gel that has adsorptive is loaded on the top of this silicagel column, carry out the low pressure dry chromatography to various granularity silica gel of 10-40 μ or tlc silica gel;
(6) with chloroform-methanol-subsurface layer solvent systems wash-out, Fractional Collections reclaims solvent, obtains panaxoside Rg 1Crude product;
(7) with above-mentioned Rg 1Crude product repeats by (four), (five), (sixs') step, obtains panaxoside Rg 1Elaboration.
The pressure range of above-mentioned described low pressure dry chromatography is 0.2-50kg/cm 2, the ratio of chloroform-methanol-water solvent system is 5-1O: 2-4: 1.
Panaxoside Rg with technology acquisition of the present invention 1, monomer whose content surpasses 90%, can be directly as the bulk drug and the functional food use of multiple medicine and pharmaceutical composition.
Embodiment
Embodiment:
Get 1.2kg Radix Notoginseng total arasaponins 30% dissolve with ethanol, solution by 30kg through pretreated D-101 macroporous resin adsorption, continue with 30% alcohol flushing resin post, the Panaxatriol saponin is washed, continue with 60-80% alcohol flushing resin post, panoxadiol type saponin is washed, the rarer pure liquid evaporated under reduced pressure of this Panaxatriol saponin is got the about 650g of Panaxatriol saponin.
Take by weighing Panaxatriol saponin 200g,, be adsorbed on the 300g80-100 order silica gel, oven dry below 60 ℃ with trying one's best 95% few ethanol heating for dissolving.Take by weighing 6kg200-300 order silica gel dress post, the thick silica gel of above-mentioned absorption 200g triol type saponin is loaded on 200-300 order silicagel column top, carry out low pressure 0.5kg/cm 2Dry chromatography with chloroform-methanol-water (7: 3: 1) lower floor solvent systems wash-out, is collected 500ml for every part, reclaims solvent, monitors panaxoside Rg with thin-layer chromatography 1The quality of crude product, wherein panaxoside Rg 1Content reach approximately about 60%, be panaxoside Rg 1The about 120g of crude product.
Take by weighing panaxoside Rg 1Crude product 50g is adsorbed on the 70g80-100 order silica gel by above-mentioned steps, oven dry.Take by weighing 500g10-40 μ silica gel H, the dress post is with above-mentioned absorption panaxoside Rg 1The silica gel of crude product is loaded on post top, carries out low pressure (0.6-0.8kg/cm 2) dry chromatography, with chloroform-methanol-water (65: 20: 10) lower floor solvent systems wash-out, collect 250ml for every part, behind the recovery solvent, monitor panaxoside Rg with thin-layer chromatography 1Quality, wherein panaxoside Rg 1Content surpasses more than 90%, through 80 ℃ of vacuum-drying 2h, detect qualified after, promptly.

Claims (1)

1, panaxoside Rg 1Preparation technology is characterized in that being made up of following steps:
(1) get Radix Notoginseng total arasaponins, the dissolve with ethanol with 10-40% obtains dilute alcohol solution;
(2) by through pretreated D-101 macroporous resin column, use the 20-40% ethanol elution;
(3) decompression recycling ethanol, spraying drying gets the Panaxatriol saponin;
(4) add a small amount of 60-100% ethanol or methyl alcohol, heating for dissolving is adsorbed on the 0.3-3 times of 40-160 order silica gel drying;
(5) get 10-50 150 orders doubly and adorn post to various granularity silica gel of 10-40 μ or tlc silica gel, the above-mentioned silica gel that has adsorptive is loaded on the top of this silicagel column, carry out the low pressure dry chromatography, pressure range is 0.2-50kg/cm 2
(6) with the ratio be 5-10: 2-4: 1 chloroform-methanol-subsurface layer solvent systems wash-out, Fractional Collections reclaims solvent, obtains panaxoside Rg 1Crude product;
(7) with above-mentioned Rg 1Crude product repeats by (four), (five), (sixs') step, obtains panaxoside Rg 1Elaboration.
CN 03148804 2003-06-12 2003-06-12 Preparation process for ginsenoside Rg1 Expired - Lifetime CN1244594C (en)

Priority Applications (1)

Application Number Priority Date Filing Date Title
CN 03148804 CN1244594C (en) 2003-06-12 2003-06-12 Preparation process for ginsenoside Rg1

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
CN 03148804 CN1244594C (en) 2003-06-12 2003-06-12 Preparation process for ginsenoside Rg1

Publications (2)

Publication Number Publication Date
CN1566138A CN1566138A (en) 2005-01-19
CN1244594C true CN1244594C (en) 2006-03-08

Family

ID=34472376

Family Applications (1)

Application Number Title Priority Date Filing Date
CN 03148804 Expired - Lifetime CN1244594C (en) 2003-06-12 2003-06-12 Preparation process for ginsenoside Rg1

Country Status (1)

Country Link
CN (1) CN1244594C (en)

Cited By (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN104011748A (en) * 2011-12-27 2014-08-27 吉列公司 Apparatus and method for providing product information

Families Citing this family (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN101463061B (en) * 2007-12-21 2013-09-18 中国医学科学院药物研究所 Ginseng saponin Rg1 and Rb1 in pseudo-ginseng and preparation of total saponin thereof
CN101829170A (en) * 2010-05-13 2010-09-15 北京中海康医药科技发展有限公司 Extract of panax notoginseng saponins and preparation method thereof
CN102453072A (en) * 2010-10-26 2012-05-16 中国医学科学院药物研究所 Preparation method of ginsenoside Rg1
CN102532234A (en) * 2010-12-10 2012-07-04 北京本草天源药物研究院 Method for extracting and purifying ginsenoside Rg1

Cited By (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN104011748A (en) * 2011-12-27 2014-08-27 吉列公司 Apparatus and method for providing product information

Also Published As

Publication number Publication date
CN1566138A (en) 2005-01-19

Similar Documents

Publication Publication Date Title
CN104610410B (en) A kind of extraction process of ginsenoside Rd
CN1244594C (en) Preparation process for ginsenoside Rg1
CN104861019A (en) Method for preparing flavonoids compounds in camellia seed shells by high-speed counter-current chromatography
CN103588785A (en) Refining method for ginkgolide A and ginkgolide B
CN102423329A (en) Decolorization method of panax notoginsenoside extract
CN1234722C (en) Preparation process for ginsenoside Rb1
CN103058978B (en) Method for synchronized preparation of pinocembrin and 2', 4'-dihydroxy chalcone from oxytropis falcate bunge
CN100423831C (en) Chromatographic fixed-phase for modified glycan substrate, its preparation and use
CN109053821A (en) The method of tea polyphenols, total amino acid, chromocor compound is extracted from grosvenor momordica leaf
CN1957962A (en) Method for preparing general saponin of golden Chinese gentian and application
CN101058597A (en) Process of preparing ardisiacrispin monomer
CN111072747A (en) Ginsenoside and ultrasonic extraction method thereof
CN102494928B (en) Preparation method for quality control grading standard product of sapindoside
CN107595906B (en) Application of hederagenin and its glucoside in preparing antiviral medicine
CN108409570A (en) Acetylshikonin rapidly and efficiently purification process in Asian puccoon
CN1272331C (en) Method of extracting effective components in kudzu vine root
CN101560145B (en) Method for separating chrysophanol and physcion by silica-gel column chromatography
CN109879850B (en) Method for preparing three polyester catechin monomers
CN1094385C (en) Modified natural macromolecular compound adsorbent and application thereof
CN1450060A (en) Method for producing isoforaxidin, eleutheroside and eleutheran from Radix Acanthopanacis senticosi
CN105330707B (en) It is a kind of while separating the Industrialized processing technique of ponticin and Rhapontin, deoxy-
CN112592381B (en) Preparation method of sapindus mukorossi triterpenoid saponin monomer
CN115466256B (en) Method for extracting, separating and purifying matrine and sophoridine from sophora alopecuroide
CN109336947B (en) Method for separating and purifying cannabinoids glycoside A from cannabis sativa
CN112657231B (en) Purification process of panax notoginseng saponins

Legal Events

Date Code Title Description
C06 Publication
PB01 Publication
C10 Entry into substantive examination
SE01 Entry into force of request for substantive examination
C14 Grant of patent or utility model
GR01 Patent grant
EE01 Entry into force of recordation of patent licensing contract

Assignee: DAPHNE PHARMACEUTICAL (GROUP) CO.,LTD. YUNNAN

Assignor: Tang Xiuwen

Contract fulfillment period: 2009.10.10 to 2015.10.9

Contract record no.: 2009530000040

Denomination of invention: Ginsenoside Rg preparation process

Granted publication date: 20060308

License type: Exclusive license

Record date: 20091013

LIC Patent licence contract for exploitation submitted for record

Free format text: EXCLUSIVE LICENSE; TIME LIMIT OF IMPLEMENTING CONTACT: 2009.10.10 TO 2015.10.9; CHANGE OF CONTRACT

Name of requester: DAPHNE PHARMACEUTICAL (GROUP) CO., LTD.YUNNAN

Effective date: 20091013

ASS Succession or assignment of patent right

Owner name: YUNNAN DAPHNE PHARMACEUTICAL CO., LTD.

Free format text: FORMER OWNER: TANG XIUWEN

Effective date: 20140416

C41 Transfer of patent application or patent right or utility model
COR Change of bibliographic data

Free format text: CORRECT: ADDRESS; FROM: 650236 YUXI, YUNNAN PROVINCE TO: 663000 YUXI, YUNNAN PROVINCE

TR01 Transfer of patent right

Effective date of registration: 20140416

Address after: 663000 37 pharmaceutical industry park, Yunnan, Wenshan

Patentee after: DAPHNE PHARMACEUTICAL (GROUP) CO.,LTD. YUNNAN

Address before: Panzhihua 650236, Yunnan province Wenshan County Township Gordon pharmaceutical factory

Patentee before: Tang Xiuwen

CX01 Expiry of patent term

Granted publication date: 20060308

CX01 Expiry of patent term